SyntekaBio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,429	120.89	123.41	243.99	316.66
Revenue Growth (YoY)	2736.72%	-2.04%	-49.42%	-22.95%	-48.06%
Cost of Revenue	4.31	3.91	2.48	10.96	15.24
Gross Profit	3,425	116.97	120.92	233.04	301.42
Selling, General & Admin	9,863	9,253	7,477	7,456	4,828
Research & Development	2,290	2,937	3,225	3,177	3,101
Amortization of Goodwill & Intangibles	100.78	101.99	181.75	148.8	111.18
Other Operating Expenses	246.62	233.5	187.25	149.85	106.24
Operating Expenses	14,190	14,387	12,397	12,025	9,193
Operating Income	-10,765	-14,270	-12,276	-11,792	-8,891
Interest Expense	-2,841	-2,008	-375.74	-1,251	-254.17
Interest & Investment Income	26.73	349.12	1,171	971.76	374.41
Currency Exchange Gain (Loss)	3.13	-8.39	-0.35	2.59	0.22
Other Non Operating Income (Expenses)	720.52	8,895	758.7	7,583	-6,032
EBT Excluding Unusual Items	-12,855	-7,042	-10,723	-4,486	-14,803
Gain (Loss) on Sale of Assets	-25.27	-5.73	-	0.13	-
Asset Writedown	-46.91	-1.26	-72	-20.25	-
Other Unusual Items	-4,450	-163.97	-603.08	-	-
Pretax Income	-17,378	-7,213	-11,398	-4,506	-14,803
Net Income	-17,378	-7,213	-11,398	-4,506	-14,803
Net Income to Common	-17,378	-7,213	-11,398	-4,506	-14,803
Shares Outstanding (Basic)	16	15	14	14	13
Shares Outstanding (Diluted)	16	15	14	14	13
Shares Change (YoY)	2.20%	6.52%	5.94%	0.37%	1.65%
EPS (Basic)	-1115.00	-473.00	-796.14	-333.47	-1099.43
EPS (Diluted)	-1115.00	-473.00	-796.14	-333.47	-1099.43
Free Cash Flow	-10,661	-16,216	-17,442	-16,899	-13,520
Free Cash Flow Per Share	-684.02	-1063.33	-1218.35	-1250.52	-1004.13
Gross Margin	99.87%	96.76%	97.99%	95.51%	95.19%
Operating Margin	-313.91%	-11804.01%	-9947.91%	-4832.99%	-2807.83%
Profit Margin	-506.76%	-5966.88%	-9235.91%	-1846.96%	-4674.69%
Free Cash Flow Margin	-310.88%	-13413.89%	-14133.89%	-6926.24%	-4269.46%
EBITDA	-8,741	-12,015	-10,514	-10,319	-7,733
EBITDA Margin	-254.90%	-	-	-	-
D&A For EBITDA	2,023	2,254	1,762	1,473	1,158
EBIT	-10,765	-14,270	-12,276	-11,792	-8,891

Source: S&P Global Market Intelligence. Standard template. Financial Sources.